Cr2o
Business Services · New York, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
16 Marconistraat, Rotterdam, New York, 1...Phone Number
+31 850717401Website
www.cr2o.nlRevenue
<$5 MillionIndustry
About Cr2o
Is Cr2o your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Cr2o recently announced quarterly report
Click to see if Cr2o had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Cr2o has recently received funding, and reach out quickly before it becomes old news!
Cr2o, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Cr2o has new funding data
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Cr2o
Check out if Cr2o is spiking on competitors!
Product Launch: Get notified when Cr2o launches new products
Recommended Actions
Find VP level buyers at Cr2o
Find 2 more new buyers
Company Profile Activity
Activity Insights
Cr2o is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Cr2o is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Cr2o.
Cr2o Tech Stack
A closer look at the technologies used by Cr2o
Cr2o News & Media
Dyadic Advancing Towards Human Clinical Trial of its SARS-CoV-2-S-RBD vaccine candidate, DYAI-100
JUPITER, Fla., March 18, 2021 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further improving, applying and deploying its proprietary C1-cell protein production platform to accelerate development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales, today announced that the Company’s initial C1 produced SARS-CoV-2-S-RBD vaccine can
Top Business Services Companies
Frequently Asked Questions Regarding Cr2o
CR2O is a full-service clinical research organization (CRO) based in the Netherlands, specializing in the design, conduct, and interpretation of complex clinical trials across various therapeutic areas. With a workforce of over 40 trained life-science professionals, CR2O offers tailored solutions and operational support throughout the product devel... Read More